XS411

· XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XS411, covering 2025-12-29 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease [Phase 1, Phase 2]